LLY hits a historic $1T valuation as booming GLP-1 sales from Mounjaro and Zepbound drive growth and expand momentum across ...

Eli Lilly has become the first pharma group to reach a value of more than $1 trillion, joining a select group of companies ...

Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by ...

Eli Lilly has achieved a landmark moment in financial markets, becoming the inaugural pharmaceutical enterprise to surpass a $1 trillion market capitalizatio ...

Eli Lilly LLY has been on an acquisition spree since the beginning of this year to bolster its pipeline, which should drive long-term growth. Although the cardiometabolic health space remains its core ...

Eli Lilly (LLY) is experiencing a banner year, as its stock price has reached new all-time highs in June. The surge comes on the heels of a series of positive developments for the pharmaceutical giant ...

Eli Lilly stock (NYSE: LLY) will report its Q3 results on Wednesday, October 30. The pharmaceutical giant is expected to garner $12.1 billion in sales and $1.45 in adjusted earnings per share, per the ...

Eli Lilly has spent the last several years reintroducing itself to the public via a series of corporate campaigns. Its latest push continues that effort but also goes a step further, inviting viewers ...

After pre-announcing that its full-year revenue would come in below its original guidance, Eli Lilly (LLY 0.51%) announced its full results and reiterated its earlier 2025 forecast. The company has ...

Eli Lilly, like a child still giddy from their first roller coaster ride, is ready to go back into space. And so it will. The pharmaceutical giant is teaming up with aerospace manufacturer Redwire for ...

Dodge & Cox, managed by John A. Gunn, recently executed a significant transaction involving Eli Lilly And Company (($LLY)).